Nutcracker Therapeutics
Developer of biotech platform disrupter designed for developing mRNA-based therapeutic drug products.
Other Pharmaceuticals and Biotechnology
📍 Emeryville, CA
Founded 2017
Current Valuation
$967M
as of 2022-Q1
PRIVATE
Developer of biotech platform disrupter designed for developing mRNA-based therapeutic drug products.
Company Profile
Last Round
Series C — $167M (Mar 2022)
Fundraising Status
Series C · $167M · 4y 3mo ago
privateTotal raised $241M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series C | $167M | Mar 2022 | — | $967M |
Health CarePharmaceuticalBiotechnologyTherapeutics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2022-Q1. Refreshed quarterly.